Abstract:BACKGROUND:How the transcriptional factors regulated the innate and adaptive immune system in pregnancy and pre-eclampsia are less understood. Nevertheless, what the plasma work in the development of this disease was not sure. The present study was design to evaluate what the transcriptional factors change in innate and adaptive immune system and what the plasma do in this filed. METHODS:Peripheral blood mononuclear cells (PBMC) from non-pregnant women (n = 18), women with clinically normal pregnancies (n = 23) and women with pre-eclampsia (n = 20) were separated from peripheral blood to isolate monocytes and T cells. The purity of monocytes and T cells were analysed by flow cytometry. Monocytes and T cells were stimulated in either lipopolysaccharides (LPS) or phorbol-myristate-acetate (PMA), respectively. Transcription Factor Arrays were used to screen the transcription factors of interest in comparing of different groups. PBMC were isolated from another 8 non-pregnant samples were co-incubated with different groups of plasma. Polymerase chain reaction (PCR) was performed using whole cell extractions of the samples. RESULTS:Nuclear factor of activated T-cells-1 (NFAT-1), signal transducers and activators of transcription-1 (STAT-1) and activator protein-1 (AP-1) are up-regulated in monocytes in pregnancy and more so in pre-eclampsia. On the the contrary, NFAT-1, STAT-1 and AP-1 are down-regulated in T cells in pregnancy and more so in pre-eclampsia. A reduction was observed in interferon (IFN)-γ, interleukin (IL)-12 and IL-4 expression in T cells incubated with pre-eclamptic plasma. An elevation was observed in tumor necrosis factor (TNF)-α, IL-1 and IL-12 expression in monocytes incubated with pre-eclamptic plasma. CONCLUSIONS:Innate immunity is over activated and adaptive immunity is over suppressed in the development of pre-eclampsia. NFAT-1, STAT-1 and AP-1 might be the central transcription factors in the pathogenesis of pre-eclampsia. They induced some changes in plasma and "educate" the monocytes and T cells for relevant cytokine production. Successful completion of this study will enhance our understanding of pre-eclampsia and will discover new knowledge beyond pregnancy. The work will inform future therapies for the treatment of a wide range of condition such as transplantation immunology and a wide range of immune and inflammatory conditions.

Changes in lymphocyte subsets during pregnancy and post-partum in cases of beginning eclampsia

Alteration of Peripheral CD4+CD25+ Regulatory T Lymphocytes in Pregnancy and Pre-Eclampsia.

Imbalance of Serum T Helper 1- and 2-Type Cytokines in Preeclampsia and Gestational Hypertension

Changes in expression levels of immune cells and inflammatory cytokines in pre-eclampsia patients before and after delivery

Placental Imbalance of Th1‐ and Th2‐type Cytokines in Preeclampsia

Elevated Serum Levels of Interleukin-15 and Interleukin-16 in Preeclampsia.

Serum Adiponectin, Leptin and Soluble Leptin Receptor in Pre-Eclampsia.

Serum and Placental Interleukin-18 Are Elevated in Preeclampsia

Changes in the Ratio of Tc1/Tc2 and Th1/Th2 Cells but Not in Subtypes of NK-Cells in Preeclampsia

Three transcription factors and the way immune cells affected by different plasma change in opposite ways in the development of the syndrome of pre-eclampsia.

Immunological Profiling of CD8+ and CD8- NK Cell Subpopulations and Immune Checkpoint Alterations in Early-Onset Preeclampsia and Healthy Pregnancy

Alterations in Serum Adipocyte Fatty Acid Binding Protein and Retinol Binding Protein-4 in Normal Pregnancy and Preeclampsia.

Study on the Level Changes of N-terminal Pro-B-type Natriuretic Peptide in the Serum of Patients with Pre-eclampsia and Its Clinical Significance

Alterations Of Serum Resistin In Normal Pregnancy And Pre-Eclampsia

CD158a+ /cd158b+ NK Cell Imbalance Correlates with Hypertension in Patients with Pre-Eclampsia.

NK,IL-12 and CRP Levels in Pregnancy with Pre-Eclampsia

Circulating Immune Cells from Early- and Late-onset Pre-eclampsia Displays Distinct Profiles with Differential Impact on Endothelial Activation

The role of Th17/Treg balance in normal pregnancy and preeclampsia

Changes of Treg and Th17 Cells in Peripheral Blood in Preeclampsia Patients and Its Signification

Immunophenotypic Characteristics of Uterine Natural Killer Cells and Helper T Cell 1/ Helper T Cell 2 Immunity in the Third Trimester Decidua of Preeclampsia Patients

ORIGINAL ARTICLE: Imbalance of T‐cell Transcription Factors Contributes to the Th1 Type Immunity Predominant in Pre‐eclampsia